The Peripheral Network between Oxidative Stress and Inflammation in Multiple Sclerosis

The Peripheral Network between Oxidative Stress and Inflammation in Multiple Sclerosis

Reactive oxygen species (ROS) are mainly produced by microglia and macrophages during inflammation-driven oxidative burst. However, they can in turn affect the reactivity and function of immune cells. For the first time, the relationship between these two key players involved in Multiple Sclerosis (...

Full description

Bibliographic Details
Main Authors:	M. Gironi, B. Borgiani, C. Cursano, M. Saresella, F. Piancone, E. Mariani, I. Marventano, V. Martinelli, G. Comi, M. Clerici, M. Rovaris, R. Furlan
Format:	Article
Language:	English
Published:	SAGE Publishing 2014-05-01
Series:	European Journal of Inflammation
Online Access:	https://doi.org/10.1177/1721727X1401200214

Similar Items

TH17-Driven Inflammation is Present in All Clinical Forms of Multiple Sclerosis; Disease Quiescence is Associated with Gata3-Expressing Cells
by: M. Saresella, et al.
Published: (2013-01-01)

Monosodium Urate Crystals Activate the Inflammasome in Primary Progressive Multiple Sclerosis
by: Federica Piancone, et al.
Published: (2018-05-01)

A novel data mining system points out hidden relationships between immunological markers in multiple sclerosis
by: Gironi Maira, et al.
Published: (2013-01-01)

Inflammatory Responses to Monomeric and Aggregated α-Synuclein in Peripheral Blood of Parkinson Disease Patients
by: Federica Piancone, et al.
Published: (2021-03-01)

Increased Levels of Beta-Endorphin and Noradrenaline after a Brief High-Impact Multidimensional Rehabilitation Program in Multiple Sclerosis
by: Alessia d’Arma, et al.
Published: (2022-05-01)

JC virus detection and JC virus-specific immunity in natalizumab-treated Multiple Sclerosis patients
by: Mancuso Roberta, et al.
Published: (2012-12-01)

Alterations in Circulating Fatty Acid Are Associated With Gut Microbiota Dysbiosis and Inflammation in Multiple Sclerosis
by: Marina Saresella, et al.
Published: (2020-07-01)

Immunological and Clinical Effect of Diet Modulation of the Gut Microbiome in Multiple Sclerosis Patients: A Pilot Study
by: Marina Saresella, et al.
Published: (2017-10-01)

The Role of the Inflammasome in Neurodegenerative Diseases
by: Federica Piancone, et al.
Published: (2021-02-01)

Neurodegeneration in multiple sclerosis /
by: Filippi, Massimo, et al.
Published: (2007)

Normal-appearing white and grey matter damage in multiple sclerosis /
by: Filippi, M., et al.
Published: (2004)

Influence of a High-Impact Multidimensional Rehabilitation Program on the Gut Microbiota of Patients with Multiple Sclerosis
by: Monica Barone, et al.
Published: (2021-07-01)

Innate immune responses to three doses of the BNT162b2 mRNA SARS-CoV-2 vaccine
by: Marina Saresella, et al.
Published: (2022-08-01)

Modulation of Neuroendocrine and Immunological Biomarkers Following Rehabilitation in Sarcopenic Patients
by: Federica Piancone, et al.
Published: (2022-08-01)

IL-33 and its decoy sST2 in patients with Alzheimer’s disease and mild cognitive impairment
by: Marina Saresella, et al.
Published: (2020-06-01)

Herpes simplex virus-1 (HSV-1) infection induces a potent but ineffective IFN-λ production in immune cells of AD and PD patients
by: Francesca La Rosa, et al.
Published: (2019-08-01)

TREM2 Expression and Amyloid-Beta Phagocytosis in Alzheimer’s Disease
by: Francesca La Rosa, et al.
Published: (2023-05-01)

The non-pathogenic protozoon Leishmania tarentolae interferes with the activation of NLRP3 inflammasome in human cells: new perspectives in the control of inflammation
by: Francesca La Rosa, et al.
Published: (2024-04-01)

Pharmacological and Epigenetic Regulators of NLRP3 Inflammasome Activation in Alzheimer’s Disease
by: Francesca La Rosa, et al.
Published: (2021-11-01)

Can rate of brain atrophy in multiple sclerosis be explained by clinical and MRI characteristics?
by: Korteweg, T, et al.
Published: (2009)

Alterations of natural killer cells activatory molecules phenotype and function in mothers of ASD children: a pilot study
by: Marina Saresella, et al.
Published: (2023-07-01)

Relationship between inflammation and oxidative stress and its effect on multiple sclerosis
by: E.J. Ramos-González, et al.
Published: (2024-04-01)

Relationship between inflammation and oxidative stress and its effect on multiple sclerosis
by: E.J. Ramos-González, et al.
Published: (2024-04-01)

Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial.
by: Filippi, M, et al.
Published: (2004)

Peripheral neuropathy in patients with multiple sclerosis.
by: Adnan Khan, et al.
Published: (2018-01-01)

Inflammation in multiple sclerosis
by: Stefanie Haase, et al.
Published: (2021-04-01)

Hydroxycitric acid ameliorates inflammation and oxidative stress in mouse models of multiple sclerosis
by: Mahdi Goudarzvand, et al.
Published: (2016-01-01)

Multiple sclerosis : recovery of function and neurorehabilitation /
by: Kesselring, Jurg, et al.
Published: (c201)

Author Correction: Transcriptional dysregulation of Interferome in experimental and human Multiple Sclerosis
by: Sundararajan Srinivasan, et al.
Published: (2018-05-01)

Modulation of MAPK- and PI3/AKT-Dependent Autophagy Signaling by Stavudine (D4T) in PBMC of Alzheimer’s Disease Patients
by: Francesca La Rosa, et al.
Published: (2022-07-01)

The oxidative stress is typical peculiarity by multiple sclerosis
by: N. V. Krotenko, et al.
Published: (2008-12-01)

Concurrent multiple sclerosis and amyotrophic lateral sclerosis: where inflammation and neurodegeneration meet?
by: Li, G, et al.
Published: (2012)

Concurrent multiple sclerosis and amyotrophic lateral sclerosis: where inflammation and neurodegeneration meet?
by: Li Grace, et al.
Published: (2012-01-01)

Vitamin D Receptor Gene Polymorphism Predicts the Outcome of Multidisciplinary Rehabilitation in Multiple Sclerosis Patients
by: Franca Rosa Guerini, et al.
Published: (2023-08-01)

The abnormality of the biochemical parameters in the peripheral blood of patients with multiple sclerosis
by: N. V. Krotenko, et al.
Published: (2008-12-01)

Inflammation-related plasma and CSF biomarkers for multiple sclerosis
by: Huang, J, et al.
Published: (2020)

Intrathecal Inflammation in Progressive Multiple Sclerosis
by: Salvatore Monaco, et al.
Published: (2020-11-01)

HLA alleles modulate EBV viral load in multiple sclerosis
by: Simone Agostini, et al.
Published: (2018-03-01)

T regulatory cells are markers of disease activity in multiple sclerosis patients.
by: Dacia Dalla Libera, et al.
Published: (2011-01-01)

Intrathecal, Not Systemic Inflammation Is Correlated With Multiple Sclerosis Severity, Especially in Progressive Multiple Sclerosis
by: Joshua L. Milstein, et al.
Published: (2019-11-01)